Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Revenue

In the year 2025, Hyloris Pharmaceuticals had annual revenue of 7.94M EUR, down -18.66%. Hyloris Pharmaceuticals had revenue of 4.60M in the half year ending December 31, 2025, with 149.19% growth.

• Revenue: 7.94M
• Revenue Growth: -18.66%
• P/S Ratio: 17.35
• Revenue / Employee: 144.35K
• Employees: 55
• Market Cap: 137.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.94M	-1.82M	-18.66%
Dec 31, 2024	9.76M	6.00M	159.64%
Dec 31, 2023	3.76M	1.37M	57.48%
Dec 31, 2022	2.39M	-709.00K	-22.90%
Dec 31, 2021	3.10M	2.92M	1,669.14%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 11, 2026

Data Sources Report a data error